An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Clinical trial NCT03060577 · COMPLETED

Trial details

NCT number: NCT03060577
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atherosclerotic Cardiovascular Disease Symptomatic Atherosclerosis Type2 Diabetes Familial Hypercholesterolemia

Start date: 2017-04-27
Primary completion: 2021-12-17
Enrollment: 382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.